Altered microRNAs as novel therapeutic approaches to cardiovascular diseases: an exciting challenge

Affiliations

¹ Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China.
² Alibaba Business College, Hangzhou Normal University, Hangzhou 310036, Zhejiang, China.
³ Department of Anesthesia, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
⁴ Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China. Electronic address: cmhnn@sina.com.

Comment

Feng Huang et al. Int J Cardiol. 2014.

. 2014 Feb 15;171(3):e84-5.

doi: 10.1016/j.ijcard.2013.11.097. Epub 2013 Dec 6.

¹ Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China.
² Alibaba Business College, Hangzhou Normal University, Hangzhou 310036, Zhejiang, China.
³ Department of Anesthesia, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
⁴ Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China. Electronic address: cmhnn@sina.com.

No abstract available

Keywords: Cardiovascular disease; Challenge; MicroRNA; Modulation; Therapeutic approach.

Comment on

Role of microRNAs in cardiac remodelling: new insights and future perspectives.
Orenes-Piñero E, Montoro-García S, Patel JV, Valdés M, Marín F, Lip GY. Orenes-Piñero E, et al. Int J Cardiol. 2013 Sep 1;167(5):1651-9. doi: 10.1016/j.ijcard.2012.09.120. Epub 2012 Oct 9. Int J Cardiol. 2013. PMID: 23063140 Review.